News

Find News

Filter articles

Applied Filters

Showing 71 to 80 of 225 results

Monsanto loses patent and trademark dispute in India

India30-03-2017

Agriculture company Monsanto has lost a patent and trademark dispute against Indian agribusiness Nuziveedu Seeds.

Global regime for bio piracy needed urgently, says commerce secretary of India

India16-03-2017

There is an urgent need for an effective global legal regime to prevent bio piracy, according to Rita Teaotia, commerce secretary of India.

Bayer loses patent battle at Delhi High Court

India08-03-2017

Bayer has been defeated in a patent battle against India-based drugs companies Alembic Pharmaceuticals and Natco Pharma today.

Otsuka to acquire Neurovance in $100m deal

Japan, US03-03-2017

Otsuka Pharmaceutical has agreed to acquire Neurovance, a privately held clinical stage pharma company.

Danish biotech company wins patent dispute at China’s Supreme Court

China21-02-2017

Danish biotechnology company Novozymes has won a patent dispute against China-based enzyme makers Shandong Longda Bio-Products and Jiangsu Boli Bioproducts at the Supreme People’s Court of China.

Fieldfisher launches second office in China

China09-02-2017

Law firm Fieldfisher has expanded its presence in China with the launch of a Shanghai office.

IP strategy chief focus for life sciences counsel, says report

International26-01-2017

Global intellectual property strategy will be the chief area of focus for IP counsel in the life sciences arena in 2017.

WTO amends TRIPS to ease poor countries’ access to medicine

International24-01-2017

The World Trade Organization has amended its intellectual property rules to make it easier for poor countries to access affordable medicines.

Merck to pay BMS and Ono $625m in patent settlement

Japan, US23-01-2017

Merck has agreed a settlement and licensing agreement with Bristol-Myers Squibb (BMS) and Ono Pharmaceutical under which it will pay the companies $625 million.

Takeda to acquire Ariad for $5.2bn

Japan, US11-01-2017

Japan-based Takeda Pharmaceutical has acquired Ariad Pharmaceuticals, a company which develops small-molecule medicines for cancer treatments, for $5.2 billion.

Showing 71 to 80 of 225 results

LSIPR